Your Guide to SMI Adviser – Advancing Interdisciplinary Care for Early Psychosis

SMI Adviser Presents: SMI Adviser is a 6-year initiative funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association. SMI Adviser’s vision is to transform care for people who have serious mental illness so that they can live their best lives. To date, the website has been accessed over 1.9 million times and has been a resource for over 70,000 interdisciplinary learners. In this presentation, we will provide clinicians a guide to the resources at SMI Adviser, with a focus on resources for working with individuals with early psychosis. We will also highlight resources that are found in our Centers of Excellence section, focusing on tools in the Clozapine and Long-Acting Injectable areas. We will also guide clinicians through our consultation service and share insights from the types of questions our users most commonly ask.

Learning Objectives
Demonstrate knowledge of the available resources on SMI Adviser’s educational catalog and knowledge base.
List and describe three tools in SMI Adviser’s Clozapine or Long-Acting Injectable Center of Excellence.
Outline the process of accessing SMI Adviser’s consultation service, demonstrating the ability to effectively seek guidance to help make evidence-based treatment decisions.

REGISTER HERE.